AR 2016

Upcoming: our results for Q1

Publication Q1 report Thursday 27 April, 22.00 CET

Webcast & teleconference Friday 28 April, 14.00 CET, +32 2 404 0659

Welcome to Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. 

Learn more about Galapagos

News

Loading...

All Galapagos news

Events

Loading...

All Galapagos events

Current Openings

Loading...

All Current Openings